Summary of Product Characteristics Updated 09-Oct-2017 | Bausch & Lomb U.K Limited
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcardBausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
+44 (0)208 781 2900
Tel: +44 (0)208 781 2991 Fax: +44 (0)208 781 295